Expertise in
12
conditions

Dr. Gareth J. Morgan

Interventional Cardiology
Children's Hospital Colorado
13123 E 16th Ave, 
Aurora, CO 
Accepting New Patients
Expertise in
12
conditions
Children's Hospital Colorado
13123 E 16th Ave, 
Aurora, CO 

Overview

Gareth Morgan is an Interventional Cardiologist practicing medicine in Aurora, Colorado.

Dr. Morgan is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Coarctation of the Aorta, Pulmonary Valve Stenosis, Smoldering Multiple Myeloma, Stent Placement, and Angioplasty.

He is actively involved in clinical research, co-authoring 573 peer reviewed articles and participating in 7 clinical trials. Dr. Morgan is currently accepting new patients.

Specialties

Interventional Cardiology

Licenses

Internal Medicine in CO

Hospital Affiliations

University Of Colorado Hospital Authority

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Denver Health Medical Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

Children's Hospital Colorado
13123 E 16th Ave, Aurora, CO 80045
Other Locations
University of Colorado Hospital
12605 E 16th Ave, Aurora, CO 80045

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Ages 65 and Under: A Trial Enrolling Subjects to Standard Total Therapy 3 (S-TT3)
UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Ages 65 and Under: A Trial Enrolling Subjects to Standard Total Therapy 3 (S-TT3)
Enrollment Status: Active_not_recruiting
Publish Date: May 22, 2026
Intervention Type: Drug
Study Drugs: M-VTD-PACE, TT3-LITE Regimen (L-TT3)
Study Phase: Phase 3
UARK 2008-03 Phase II Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy (No Prior Transplant)
UARK 2008-03 Phase II Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy (No Prior Transplant)
Enrollment Status: Active_not_recruiting
Publish Date: May 11, 2026
Intervention Type: Drug
Study Drugs: Melphalan, Velcade, Thalidomide, Dexamethasone, Cisplatin, Adriamycin, Cyclophosphamide, Etoposide
Study Phase: Phase 2
A Phase II Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-Host-Exhausting and Timely Dose-Reduced Mel-80-CFZ-TD-Pace Transplant(s) With Interspersed Mel-20-CFZ-TD-Pace With CFZ-RD and CFZ-D Maintenance
A Phase II Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-Host-Exhausting and Timely Dose-Reduced Mel-80-CFZ-TD-Pace Transplant(s) With Interspersed Mel-20-CFZ-TD-Pace With CFZ-RD and CFZ-D Maintenance
Enrollment Status: Terminated
Publish Date: June 22, 2021
Intervention Type: Drug, Device
Study Drug: MEL-CFZ-TD-PACE
Study Phase: Phase 2
Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment Relapsed/Refractory Multiple Myeloma Patients
Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment Relapsed/Refractory Multiple Myeloma Patients
Enrollment Status: Completed
Publish Date: June 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS, With Cyclophosphamide, in Patients With Recurrent of Refractory Multiple Myeloma
A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS, With Cyclophosphamide, in Patients With Recurrent of Refractory Multiple Myeloma
Enrollment Status: Completed
Publish Date: October 19, 2020
Intervention Type: Drug
Study Phase: Phase 2
UARK 2010-35, A Phase II Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma
UARK 2010-35, A Phase II Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma
Enrollment Status: Completed
Publish Date: May 19, 2017
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Trial of a Novel Proteasome/IMiD Combination, Ixazomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Patients
A Phase II Trial of a Novel Proteasome/IMiD Combination, Ixazomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Patients
Enrollment Status: Withdrawn
Publish Date: January 23, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

573 Total Publications

Access to atrial flow regulators for implantation in critically ill children via the US Food and Drug Administration's emergency use pathway.
Access to atrial flow regulators for implantation in critically ill children via the US Food and Drug Administration's emergency use pathway.
Journal: The Journal of invasive cardiology
Published: July 29, 2026
Similar Doctors
Expertise in
26
conditions
Dr. Matthew M. Zipse
Interventional Cardiology | Cardiac Electrophysiology | Cardiology
Expertise in
26
conditions
Dr. Matthew M. Zipse
Interventional Cardiology | Cardiac Electrophysiology | Cardiology
Referral may be required

University Physicians Incorporated

13123 E 16th Ave, 
Aurora, CO 
 (0.1 miles away)
720-777-1234
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Matthew Zipse is an Interventional Cardiologist and a Cardiac Electrophysiologist practicing medicine in Aurora, Colorado. Dr. Zipse is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Arrhythmias, Ventricular Tachycardia, Sarcoidosis, Cardiac Ablation, and Pacemaker Implantation. Dr. Zipse is currently accepting new patients.

Expertise in
12
conditions
Dr. Ehrin J. Armstrong
Interventional Cardiology
Expertise in
12
conditions
Dr. Ehrin J. Armstrong
Interventional Cardiology
Referral may be required

Advanced Heart And Vein Center Inc

805 E 144th Ave Ste 100, 
Thornton, CO 
 (18.6 miles away)
720-772-8040
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ehrin Armstrong is an Interventional Cardiologist practicing medicine in Thornton, Colorado. Dr. Armstrong is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Peripheral Artery Disease, Atherosclerosis, Heart Attack, Angioplasty, and Atherectomy. Dr. Armstrong is board certified in American Board Of Internal Medicine. Dr. Armstrong is currently accepting new patients.

Expertise in
15
conditions
Dr. John C. Messenger
Interventional Cardiology
Expertise in
15
conditions
Dr. John C. Messenger
Interventional Cardiology
Referral may be required

Office

12401 E 17th Ave Ste 524, 
Aurora, CO 
 (0.4 miles away)
720-848-6508
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Messenger is an Interventional Cardiologist practicing medicine in Aurora, Colorado. Dr. Messenger is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Heart Attack, Aortic Valve Stenosis, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR). Dr. Messenger is currently accepting new patients.

Frequently Asked Questions about Dr. Gareth J. Morgan

How do I make an appointment with Dr. Gareth J. Morgan?

You can book an appointment with Dr. Gareth J. Morgan by calling their office at 720-777-3376. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gareth J. Morgan a top-rated expert for Coarctation of the Aorta?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gareth J. Morgan is classified as an Elite expert for Coarctation of the Aorta, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gareth J. Morgan specialize in?

While Dr. Gareth J. Morgan is a Interventional Cardiology, they have specific expertise in Coarctation of the Aorta, Pulmonary Valve Stenosis, and Smoldering Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Interventional Cardiology.

Does Dr. Gareth J. Morgan participate in research or clinical trials?

Yes. Dr. Gareth J. Morgan has published 573 articles and abstracts on conditions like Coarctation of the Aorta. You can view a list of Dr. Gareth J. Morgan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gareth J. Morgan accept my insurance?

Dr. Gareth J. Morgan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 720-777-3376 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Morgan's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile